PTSD in Cancer Patients: What Providers Need to Know
Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care. -
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease. -
Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not. -
Lymphoma Patients Show Continued Cognitive Decline After Chemotherapy
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
HEMATOLOGIC CANCER NEWS
Ibrutinib Not Recommended Over ‘Watch and Wait’ in Asymptomatic, Early CLL
CEBPA-bZip Mutations Associated With Favorable Prognosis in Acute Myeloid Leukemia
Qualitative Study Sheds Light on Patient Trust in Shared Decision Making in MM Treatment
Trial Evaluating Entospletinib Plus Chemo in NPM1-Mutated Acute Myeloid Leukemia
Researchers Seeking Optimal Dose of Idelalisib for Follicular Lymphoma Patients With No Other Options
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
Loading... 
Loading...